Caris & Company Starts Emdeon (EM) at Above Average
More News related to EM
- Emdeon to Present at the Piper Jaffray Annual Health Care Conference
- Emdeon CEO Pens Chapter in 'Stop Paying the Crooks: Solutions to End the Fraud That Threatens Your Healthcare'
- Morgan Stanley Upgrades Emdeon (EM) to Overweight
- U.S. Healthcare Efficiency Index(TM) Launches Primary Data Collection to Measure Current State of Electronic Adoption and Potential Cost Savings
- After-Hours Movers 11/10: BITS, GSB, OCNF, HOO Higher; TGIC, MCZ, STV, MBLX, EM Lower
Caris & Company initiates coveage on Emdeon (NYSE: EM) with an Above Average rating and $19 price target.
For more analyst ratings on EM click here.
Emdeon, Inc. provides revenue and payment cycle management solutions that connect payers, providers, and patients in the United States healthcare system.
Related Categories
New CoverageStocks Mentioned
-0.31Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
